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A r t i c l e s
To newly identify loci for age at natural menopause, we carried out a meta-analysis of 22 genome-wide association studies (GWAS) in 38,968 women of European descent, with replication in up to 14,435 women. In addition to four known loci, we identified 13 loci newly associated with age at natural menopause (at P < 5 × 10 −8 ). Candidate genes located at these newly associated loci include genes implicated in DNA repair (EXO1, HELQ, UIMC1, FAM175A, FANCI, TLK1, POLG and PRIM1) and immune function (IL11, NLRP11 and PRRC2A (also known as BAT2)). Gene-set enrichment pathway analyses using the full GWAS data set identified exoDNase, NF-kB signaling and mitochondrial dysfunction as biological processes related to timing of menopause.
RESULTS
In our discovery stage of 38,968 women with natural menopause aged (Supplementary Tables 1 and 2) , we identified 20 regions with SNPs meeting the genome-wide significance criterion P < 5 × 10 −8 ( Fig. 1) . Four of these loci confirmed earlier reports of associations on chromosomes 5, 6, 19 and 20 (refs. 14,15 ; regions 5b, 6a, 19a and 20, respectively, in Table 1 ) and 16 loci were previously unidentified. We did not confirm one reported association on chromosome 13 (13q34, rs7333181, P = 0.12). The overall genomic inflation factor was 1.03 ( Fig. 1, inset ; SNP with lowest P value from each region, Table 1 ). There was no between-study effect heterogeneity across discovery studies (P > 0.05/20 = 0.0025) for the 20 SNP associations presented. Within the Framingham Heart Study group, we tested for differences in effect size for the 20 SNPs in retrospectively and prospectively collected menopause age, and found no significant differences (data not shown). The effect sizes ranged from 0.17 years (8.7 weeks) to nearly 1 year (50.5 weeks) per each copy of the minor allele. We computed the effect sizes for dichotomized age at natural menopause in women from the Women's Genome Health Study (WGHS). For early menopause, we compared women with age at menopause <45 (N = 745) to those with age at menopause >45. For late menopause, we compared women with age at menopause >54 (N = 1,632) to those with age at menopause <54. The estimated odds ratios for early menopause for the menopause-decreasing allele ranged from 1.01 to 2.03. The estimated odds ratios for late menopause for the menopause-decreasing allele ranged from 0.52 to 0.96 (Supplementary Table 3 ). The top SNPs in regions 2c, 5a and 19b were >400 kb but <1 Mb from the top SNP in another region on the same chromosome. The top SNP in each of these primary regions had low linkage disequilibrium (LD; r 2 < 0.5) with the top SNP in the nearby region. To determine whether these associations were independent, we carried out a conditional association analysis in the discovery study samples with the most significant SNP from each of the primary 17 regions included as covariates in the analysis. For regions 5a and 19b (rs890835 and rs12461110, respectively), the effect estimates in the conditional analysis were unchanged compared Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways
Menopause is the cessation of reproductive function of the human ovaries. This life stage is associated with one of the major hormonal changes of women, characterized by a decline in secretion of estrogen, progesterone and, to a lesser degree, testosterone. It influences a woman's well-being and is associated with several major age-related diseases including cardiovascular disease, breast cancer, osteoarthritis and osteoporosis 1 . Ovarian aging is reflected by the continuous decline of the primordial follicle pool, which is established during fetal life, subsequently leading to endocrine changes owing to loss of the negative feedback from ovarian hormones on the hypothalamicpituitary axis. In addition to follicle loss, oocyte quality diminishes with increasing age, which is believed to be due to greater meiotic nondisjunction 2 . Oocyte quality may be controlled at the time germ cells are formed during fetal life, but it may also reflect accumulated damage during reproductive life and/or age-related changes in granulosa cell-oocyte communication 3 . Although both oocyte quantity and quality decline with increasing age, it is unclear whether they are controlled by the same mechanisms and whether they decline in parallel.
The average age at natural menopause in women of Northern European descent is 50-51 years (range 40-60 years) 4 . Heritability estimates from twin and family studies for age at natural menopause range from 44% to 65% (refs. 5-8) . Thus far most genetic association studies regarding age at menopause have focused on candidate genes 9 from the estrogen pathway 10, 11 or vascular components 12, 13 . Recently, two GWAS have newly identified five loci associated with age at natural menopause on chromosomes 5, 6, 13, 19 and 20 (refs. 14,15) . These loci, however, explained <1.5% of the phenotypic variation of age at natural menopause, suggesting that additional loci of small effect will probably be discovered in larger samples. Therefore, we conducted a two-stage GWAS of women of European ancestry, combining the women from the two previous GWAS 14, 15 with new participants for a total of 38,968 women from 22 studies in the discovery stage, and 14,435 women from 21 studies in the replication stage.
with in the discovery analysis (differences of 0.3% and 4%, respectively), and the P values were genome-wide significant. However, for region 2c, the effect size was ~12.5% lower in the conditional analysis than in the initial analysis, and the SNP P value was no longer genome-wide significant (P = 9.8 × 10 −7 ; Table 1 ), suggesting that the association with rs7606918 is not independent of the rs1018348 region 2b association. We attempted replication only for the 19 SNPs that represented independent regions that reached genomewide significance (P < 5 × 10 −8 ), thus we did not pursue replication of rs7606918.
Replication
We used 21 studies contributing 14,435 women for replication of the 19 SNPs that defined the independent genome-wide significant regions from stage 1. We defined age at natural menopause using the same criteria as in the discovery studies (Supplementary Table 1) . Of these studies, 17 (n = 6,639) were included in in silico replication (Supplementary Table 2) ; an additional 4 studies (n = 7,796) contributed de novo genotypes for the 19 SNPs (Supplementary Table 2 ; effect sizes and P values for replication and combined meta-analysis of discovery and replication samples, Table 1 ). There was no evidence for effect heterogeneity among the replication studies ( Table 1) . We also tested for heterogeneity between the in silico and de novo genotyped studies, and found no evidence for heterogeneity of effect (data not shown), suggesting that for the significant SNPs, the genotype imputation methods did not lead to significantly different effect size estimates than would have been obtained from direct genotyping. Of the 19 SNPs, 17 were genome-wide significant and had lower P values in combined meta-analysis of the discovery and replication samples. Regions 5a and 13a showed no evidence of association in the replication samples (P > 0.50) and were not genome-wide significant in combined discovery and replication meta-analysis. Four of the 17 replicated regions have been reported previously; thus our analysis identified 13 regions newly associated with age at natural menopause on the basis of genome-wide significant discovery with replication. In the combined discovery and replication meta-analyses, the effect estimates ranged from 8.2 to 49.3 weeks per minor allele. The estimated proportion of variance explained by the 17 replicated SNPs in the four replication studies with de novo-genotyped SNPs varied from 2.5% (Osteos) to 3.7% (EPOS and BWHHS) to 4.1% (PROSPECT-EPIC).
We used the largest study contributing data to our discovery GWAS (WGHS, n = 11,379) to explore whether substantial SNP-SNP interactions are present among the 17 replicated SNPs. We tested all 136 pairs of SNPs and found no evidence for interaction (all P > 0.01).
Roles of genes at or near newly identified loci
All but two of the replicated SNPs are intronic or exonic to known genes ( Table 2 ). The top SNPs in regions 6b, 12, 19b and 20 are missense polymorphisms. Three of the four have been predicted to have damaging protein function by SIFT 16 , and one by PolyPhen2 (ref. 17) . Using dbSNP and LocusZoom 18 , we identified the genes underlying the newly identified top regions. We used SCAN (see URLs) to identify all genes with SNPs that are in LD (r 2 > 0.5) with our SNPs ( Table 2) . We identified all SNPs with r 2 ≥ 0.8 with our top SNPs and used several databases to determine whether the SNPs are associated with expression ( Table 2 ).
The strongest new signal was on chromosome 4 (region 4, rs4693089; P = 2.4 × 10 −19 ). The SNP is located in an intron of HELQ, which encodes the protein HEL308, a DNA-dependent ATPase and DNA helicase 19 . The second strongest new signal was on chromosome 12 (region 12, rs2277339; P = 2.5 × 10 −19 ). This SNP is a nonsynonymous variant in exon 1 of PRIM1. The top SNP was significantly associated with expression of PRIM1 in visual cortex, cerebellum and prefrontal cortex ( Table 2) .
Several other previously unidentified signals are located in introns of genes for which mouse models exist. These were region 8 in ASH2L (rs2517388; P = 9.3 × 10 −15 ), region 15 in POLG (rs2307449; P = 3.6 × 10 −13 ) and region 1b in EXO1 (rs1635501; P = 8.5 × 10 −10 ). ASH2L encodes a trithorax group protein, and is involved in X chromosome inactivation in women 20 . POLG encodes the catalytic subunit of mitochondrial DNA polymerase, the enzyme responsible for replication and repair 21 of mitochondrial DNA. EXO1 is a member of the RAD2 nuclease family of proteins, which is involved in DNA replication, repair and recombination, and the top hit is in LD (r 2 = 0.83) with a functional polymorphism in EXO1 that affects a transcription factor-binding site in the promoter. Region 11 (rs12294104; P = 1.5 × 10 −11 ) is near and in LD (r 2 = 0.92) with SNPs in FSHB. Transcription of FSHB limits the rate of production of the heterodimeric folliclestimulating hormone (FSH), a key pituitary gland-expressed hormone that stimulates maturation of follicles. Region 19a (rs11668344; P = 1.5 × 10 −59 ) is in tight LD with SNPs in IL11; this cytokine stimulates the T cell-dependent development of immunoglobulinproducing B cells.
The top SNPs in two other previously unknown regions are nonsynonymous coding variants. Region 6b, rs1046089 (P = 1.6 × 10 −16 ), is in exon 22 of PRRC2A and was associated with expression of several transcripts in the human leukocyte antigen (HLA) region in several tissues ( Table 2) . Region 19b, rs12461110 (P = 8.7 × 10 −10 ) is in exon 5 of NLRP11. PRRC2A encodes HLA-B associated transcript 2 and has several microsatellite repeats. NLRP11 encodes the nucleotidebinding domain and leucine-rich repeat-containing (NLR) family pyrin domain-containing 11 protein, which is implicated in the activation of proinflammatory caspases 22 .
Of the remaining five new regions, the top SNPs for regions 1a, 2a, 2b and 13b are located in introns. These were rs4246511 in RHBDL2 (0.24 years per minor allele, P = 9.1 × 10 −17 ), which is thought to function as an intramembrane serine protease; rs2303369 in FNDC4, which encodes fibronectin type III domain-containing 4 (P = 2.3 × 10 −12 ); A r t i c l e s Chr., chromosome. MAF, minor allele frequency. Heterogeneity, P values for heterogeneity among discovery studies and replication studies, and comparing all discovery to all replication studies. P value, replication P values that meet the criterion P < 0.05/19 ≈ 0.026 are in bold. Combined analysis P values that reached genome-wide significance are in bold.
A r t i c l e s a Arg > His; predicted to be damaging (SIFT), benign (Polyphen2). b Asp > Ala; predicted to be damaging (SIFT), probably damaging (Polyphen2). c Pro > Leu; predicted to be damaging (SIFT), benign (Polyphen2). d Glu > Lys; predicted to be tolerated (SIFT), benign (Polyphen2).
A r t i c l e s rs10183486 in TLK1 (P = 2.2 × 10 −14 ), a nuclear serine-threonine kinase that is potentially involved in the regulation of chromatin assembly; and rs4886238 in TDRD3 (P = 9.5 × 10 −11 ). TDRD3 is a binding partner for FMR1, which has been associated with primary ovarian insufficiency (POI). The top SNP in the final newly identified region, 16, is within 60 kb of three genes, TNFRSF17, GSPT1 and RUNDC2A. It is in LD (r 2 > 0.5) with SNPs in these three genes and four others (rs10852344; P = 1.0 × 10 −11 ; Table 2 ).
Pathway analyses
We used three independent pathway-based methods to identify connections among our single-marker associations and link them with broader biological processes. Although all three approaches (ingenuity pathway analysis (IPA, see URLs), MAGENTA 23 and GRAIL 24 ) are based on published data, thus linking the gene products of our top hits to each other in functional pathways, each uses a substantially different methodology and uses different aspects of our results as input. Thus, we expect complementary results from the three approaches. We used IPA (see URLs) to identify potential biological pathways common to the 17 replicated SNPs. On the basis of the genes physically nearest the 17 loci, we identified four major functional networks applying direct interactions only (Supplementary Table 4 ). Network 1, related to lipid metabolism, molecular transport and small molecule biochemistry, contained 14 of the genes nearest the menopause loci (P = 1 × 10 −30 ). Central to this network is the HNF4A gene, which has a role in diabetes. Network 2, containing 12 of the input genes, relates to cell cycle, cell death and cancer (P = 1 × 10 −24 ). The ESR1 gene is central in this network, suggesting that genes in this network influence or are influenced by estrogen signaling. Network 3 is also partially related to cell death, and includes TNF and NF-κB (P = 1 × 10 −19 ). Network 4 relates to infection mechanism, DNA replication, recombination and repair and gene expression (P = 1 × 10 −12 ). Notably, several of the input genes included in network 1 (EXO1 and HELQ) and network 2 (UIMC1, FANCI and TLK1) are also involved in DNA repair mechanisms.
We used gene set enrichment analysis (GSEA) implemented in MAGENTA 23 to explore pathway-based associations using the full GWAS results. Three pathways reached study-wide significance (false discovery rate (FDR) < 0.05), exoDNase (P = 0.0005), NF-κB signaling (P = 0.0006) and mitochondrial dysfunction (P = 0.0001; Supplementary Table 5) .
Finally, we used the GRAIL method of literature-based pathway analysis 24 to explore the connections between genes near our top SNPs. Genes are considered related if they share informative words. GRAIL scores for genes associated with three of the replicating genome-wide significant SNPs were significant, EXO1, FKBPL and BRSK1. When we applied this method to a deeper set of 66 SNPs from the discovery meta-analysis with significance meeting FDR < 0.05, 12 genes had significant GRAIL scores: EXO1, MSH6, PARL, RHBDL2, FKBPL, TP53BP1, TLK1, RAD54L, CHEK2, H2AFX, APEX1 and REV3L. BRSK1 was also borderline significant with GRAIL FDR = 0.06.
Candidate genes
Within the discovery GWAS, 18,327 SNPs were within 60 kb of the start and end of transcription of 125 candidate genes selected because of a reported relationship with ovarian function (Supplementary Table 6 ). After multiple testing correction, 101 SNPs in or near five of the candidate genes (DMC1, EIF2B4, FSHB, POLG and RFPL4A) were significantly associated with age at natural menopause. SNPs in or near four of these genes were already identified as genome-wide significant (EIF2B4, region 2a; RFPL4A, region 19b; POLG, region 15; and FSHB, region 11). For the other gene, DMC1, the most significant SNP was rs763121, with nominal P = 1.6 × 10 −7 (P = 0.0009 corrected for candidate gene SNP analyses); age at natural menopause was lower by ~0.18 years per copy of the minor allele. DMC1 encodes a protein that is essential for meiotic homologous recombination and is regulated by NOBOX, mutations in which can cause POI [25] [26] [27] .
Pleiotropy of primary hits
We examined overlap of our significant regions against published GWAS results for other traits (GWAS catalog; see URLs). Twelve menopause loci were within 1 Mb of a previously published genomewide significant SNP, but most of the colocalized SNPs were in low LD (0 < r 2 < 0.21) with our SNP in the region (Supplementary Table 7) . The exception was at the GCKR locus on chromosome 2. Region 2a (rs2303369) was correlated (r 2 ≈ 0.5) with four different SNPs reported to influence kidney function, type 2 diabetes, continuous glycemic traits, as well as serum albumin, C reactive protein, serum urate, and triglycerides. These results increase the observed clustering of signals in complex trait genetics, whilst also adding to the increasing pleiotropy observed at the GCKR locus.
DISCUSSION
In this large two-stage GWAS, we confirmed four established menopause loci and identified and replicated 13 loci newly associated with age at natural menopause. Of these 17 hits, all but two are intronic or exonic to known genes. For associated SNPs in GWAS, on average 40% are intergenic, whereas only 2% of our hits are intergenic. Furthermore, we found twice the nonsynonymous top hits typically observed in GWAS (24% versus 12%; ref. 28 ). The 17 replicated loci function in diverse pathways including hormonal regulation, immune function and DNA repair. Together, they explained 2.5-4.1% of the population variation in menopausal age in independent replication samples. Biological pathway analysis of the genetic associations with age at natural menopause in this study using distinct algorithms and databases were in close agreement in emphasizing general biological pathways for mitochondrial function, DNA repair, cell cycle and cell death and immune response.
Aging is thought to result from the accumulation of somatic damage 29 . Analysis of gene expression patterns in aging organs, such as heart and brain, identified changes in genes involved in inflammatory response, oxidative stress and genome stability 30 , processes also identified in analysis of age-related changes in mouse oocytes, including changes in mitochondrial function 31 . Comparisons of lifespans across species show that longevity and DNA repair function are generally related 32 . This notion is reinforced in the Werner and Bloom syndromes, which involve genome instability due to mutations in 3′→5′ DNA helicases of the RecQ family members, and are characterized by both premature aging and premature menopause 33 . Similarly, an increase in meiotic errors is associated with an age-related decline in oocyte quality, compounding progress toward menopause owing to follicle depletion 34 .
In biological pathway analysis, seven candidate genes identified by proximity to the 17 genome-wide significant associations with age at natural menopause are related to DNA damage repair and replication (EXO1, HELQ, UIMC1, FAM175A, FANCI, TLK1, POLG and PRIM1; Supplementary Table 4 ). The protein encoded by UIMC1 physically interacts with BRCA1 and estrogen receptor α and is thought to recruit BRCA1 to DNA damage sites and to initiate checkpoint control in the G2/M phase of the cell cycle. PRIM1 (primase) is involved in DNA replication by synthesizing RNA primers for Okazaki fragments during discontinuous replication 35 . A mutation in POLG can segregate with POI 36 . Polg knock-in mice show lower lifespan, premature aging A r t i c l e s and lower fertility compared with wild type 37 . FANCI, another gene at the same locus adjacent to POLG, is a member of the Fanconi anemia complementation group. Fanconi anemia is a recessive disorder characterized by cytogenetic instability and defective DNA repair. Fanconi anemia patients experience irregular menstruation with menopause occurring around age 30 (ref. 38) . The functional polymorphism correlated to our top hit in EXO1 is associated with longevity in female centenarians 39 . Male and female Exo1 knockout mice are sterile because the gene is essential for male and female meiosis 40 . In addition to the GWAS regions in or near genes associated with early menopause, we investigated a panel of candidate genes identified before the study, and found a SNP near the meiotic recombination gene DMC1 to be significantly associated with age at menopause. How the DNA repair pathways contribute to menopause remains unclear. With altered DNA repair mechanisms, damage could accumulate, rendering poor-quality oocytes for selection. In contrast, the number of damaged follicles may increase with aging, leading to a greater rate of follicle loss through atresia. The top hit in this study, a nonsynonymous SNP in MCM8, was not included in the IPA results, probably because the exact function of this protein is still unknown. The MCM family, however, is a key component of the prereplication complex, and its main function is to restrict DNA replication to one round per cell cycle 41 .
The pathway analyses highlighted additional candidate genes with functions in DNA repair, but with subgenome-wide levels of significance for association with age of natural menopause. These 12 candidates (Supplementary Table 5 ) included the gene encoding Werner helicase (WRN), mutations in which cause Werner syndrome, a classic progeria with advanced aging phenotype and ovarian aging 42 . Estrogen can enhance WRN expression, preventing cell senescence, suggesting that WRN is involved in menopause 43 . The identification of DNA repair as one of the biological pathways involved in menopause may also explain the association between smoking and an earlier age at menopause. Damage caused by smoking activates several different DNA repair mechanisms. Indeed, a polymorphism in Exo1, one of our top loci, is associated with colorectal adenomas in smokers only 44 . Additional studies are needed to determine whether smoking status modifies the association between age at natural menopause and polymorphisms in DNA repair genes, as has been observed for various cancers.
Pathway-based analysis indicated that genes related to autoimmune disease also influence age at natural menopause. This link has not been reported before, however, in a proportion (2-10%) of women with POI, ovarian autoimmunity can have a role 45 . POI is frequently associated with additional autoimmune diseases, such as type 1 diabetes mellitus 46 . The top SNP in region 19a is near IL11, which binds the interleukin 11 (IL-11) receptor α chain. Female mice with null mutations in Il11ra are infertile owing to defective uterine decidualization, the process necessary for successful embryo implantation 47 . NLRP11 (region 19b) is a member of the NLRP family of genes, which have important roles in the innate immune system and reproductive system. Several NLRP genes show an oocyte-specific expression pattern 46 , whereas NLRP5 has been implicated in POI, and serves as an autoantigen in a mouse model of autoimmune POI 48, 49 . Many autoimmune conditions are associated with a particular HLA type, but no such association has been reported for POI 50, 51 . One of our top menopause associations (rs1046089) is a missense substitution in PRRC2A (HLA-B-associated transcript), which is in the HLA class III complex on chromosome 6 and has been associated with type I diabetes mellitus and rheumatoid arthritis. Multiple phenotypes have been associated with PRRC2A SNPs in GWAS, including BMI, neonatal lupus, HIV control and height (Supplementary Table 7) , but the SNPs have low correlation with our top hit. Expression data for rs1046089 show that the polymorphism was associated with altered expression of HLA-DRB4 in monocytes and HLA-DQA1 in lymphoblastoid cell lines ( Table 2) . Thus, this gene is a candidate for a proinflammatory component to oocyte depletion that affects menopause age. Indeed, the enrichment of genes involved in NF-κB signaling (TNF, TNFRSF17 and CSNK2B) in biological pathway analysis suggests that susceptibility to inflammation, which often accompanies immunosenescence in aging, may also affect ovarian aging. The finding that the innate immune response can be upregulated in response to DNA damage 52 suggests that interplay between the two main pathways we identified (DNA repair and inflammation) may contribute to variation in age at natural menopause.
Three of the 17 regions can be linked to hormonal regulation, an additional route to follicle pool exhaustion. The top SNP in region 11 (rs12294104) is in high LD with SNPs in FSHB (r 2 = 0.92, Table 2 ), which limits the rate of production of FSH, a key pituitary glandexpressed hormone that stimulates maturation of follicles. FSH-deficient female mice are infertile 53 . Transgenic mice that overexpress FSH show premature infertility owing to postimplantation reduction of embryofetal survival 54 . FSH concentrations rise in women approaching menopause; this might be related to a decrease in growing follicles 55 . Mutations in FSHB cause hypogonadism and primary amenorrhea in women 56 and lead to greater FSH concentrations and infertility in males compared with wild type 57 . The latter observation is due to a promoter polymorphism that may be causal 58 and is in LD (r 2 = 0.7) with our most significant SNP. Although STAR, which encodes steroidogenic acute regulatory protein (StAR), was not the nearest gene to the top SNP in region 8 (rs2517388), its functional role in cleavage of cholesterol to pregnenolone in response to tropic hormones makes it a probable functional candidate, and our top SNP is in high LD with SNPs in that gene (r 2 = 0.81, Table 2 ). Pregnenolone is a precursor for several steroid hormones, such as estrogen and progesterone, and mutations in the STAR gene are associated with congenital lipoid adrenal hyperplasia and POI 59 . Furthermore, STAR is a target of FOXL2, for which truncating mutations are preferentially associated with POI 60 . Similarly, BCAR4, which encodes the breast cancer antiestrogen resistance 4 protein, is the best candidate gene near region 16. BCAR4 is expressed only in placenta and oocytes and may have a role in hormonal stimulation in the ovary. In breast cancer treatment, tumors highly expressing BCAR4 are more resistant to tamoxifen treatment 61 , reinforcing the role of BCAR4 in transduction of hormonal signals.
In summary, our findings demonstrate the role of genes that regulate DNA repair and immune function, and genes affecting neuroendocrine pathways of ovarian function in regulating age at menopause, indicating that the process of aging is involved in both somatic and germ line aging.
We expect that several additional common variants with small effects on age at natural menopause are yet to be identified, and that many of them are in genes in pathways identified in this study. Sequencing and exome chip studies to determine whether lowfrequency and rare variants of large effect also contribute to age at natural menopause are underway or being planned in many of the cohorts involved in this GWAS. A collaboration of several consortia is examining the contribution of common genetic variants to age at natural menopause in African-American women, and could allow researchers to determine whether the genetic variation that affects age at natural menopause in African-American women is the same or substantially different from that for women of primarily European descent. We are now conducting a study of women with POI to determine whether variants associated with age at natural menopause A r t i c l e s within the normal range of age 40−60 also contribute to disease conditions related to the early-menopause phenotype.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/. 
ONLINE METhODS
Discovery. Age at natural menopause was defined as age at last menstrual period that occurred naturally with at least 12 consecutive months of amenorrhea. This analysis included women with natural menopause aged 40-60. Women of self-reported non-European ancestry were excluded, as were women with menopause owing to hysterectomy and/or bilateral ovariectomy, chemotherapy or irradiation, if validated by medical records, and women using HRT before menopause. Most cohorts collected age at natural menopause retrospectively; in the Framingham Offspring, the Atherosclerosis Risk in Communities Study (ARIC), Nurses Health Study (NHS) and WGHS studies, some women became menopausal under study observation. Study-specific questions, mean age at menopause and age at interview are in Supplementary  Table 1 . Genotyping and imputation information for discovery cohorts are in Supplementary Table 2 . Descriptions of each study are in Supplementary Note. For all studies participating in the meta-analyses, each participant provided written informed consent. The Institutional Review Board at the parent institution for each respective cohort approved the study protocol.
Replication. A total of 14,435 women from 21 studies meeting the same inclusion and exclusion criteria as the women in discovery analysis were included in replication analysis. The women had mean and s.d. of age at natural menopause similar to the discovery set (Supplementary Table 1 The 19 independent genome-wide significant SNPs were tested for association with age at natural menopause using linear regression models. Meta-analysis inverse variance weighted meta-analysis of the studies was done with METAL using genomic control 62 . A SNP within a study was omitted if the minor allele frequency was <1% or imputation quality score was <0.2. The discovery metaanalysis included 2,551,160 autosomal SNPs and 38,968 samples.
Expression quantitative trait locus analysis. For each of the genome-wide significant menopause SNPs (Table 1) , all proxy SNPs with r 2 > 0.8 were determined in HapMap CEU release 22. Each SNP and its proxies were searched against a collected database of expression quantitative trait locus (eQTL) results, including the following tissues: fresh lymphocytes 63 , fresh leukocytes 64 , leukocyte samples in individuals with Celiac disease 65 , lymphoblastoid cell lines (LCLs) derived from asthmatic children 66 , HapMap LCLs from three populations 67 , HapMap CEU LCLs 68 , fibroblasts, T cells and LCLs derived from cord blood 69 , peripheral blood monocytes 70, 71 , CD4 + lymphocytes 72 , adipose and blood samples 73 , brain cortex 70, 74 , brain regions including prefrontal cortex, visual cortex and cerebellum (three large studies; V.E., unpublished data), cerebellum, frontal cortex, temporal cortex and caudal pons 75 , prefrontal cortex 76 , liver 77 and osteoblasts 78 . The collected eQTL results met criteria for statistical significance for association with gene transcript levels as described in the original papers. eQTL findings for replicated GWAS SNPs are summarized in Table 2 .
Conditional analysis. On each chromosome, SNPs of the lowest P value that met genome-wide significance were identified. Genome-wide-significant SNPs >250,000 bp and <1 Mb apart that also had pairwise HapMap CEU LD values of r 2 < 0.5 were considered potentially independent regions. Potential independent regions that were within 1 Mb of a second region with a more significant P value were tested for independence using conditional analysis. In this analysis, the most significant SNP in the most significant region on each chromosome was used as a covariate in a genome-wide analysis. The second region on the chromosome was then retested for independent association. Pathway analyses. IPA Knowledge Base 8.8 (see URLs) was used to explore the functional relationship between proteins encoded by the 17 replicated menopause loci. The IPA Knowledge Base contains millions of findings curated from the literature. All reference genes (n = 61) within 60 kb potentially encoded by the 17 loci ( Table 2) were entered into the Ingenuity database. Fifty-one genes were eligible for pathway analysis. These eligible 'focus genes' were analyzed for direct interactions only. Networks were generated with a maximum size of 35 genes and molecular relationships between genes or gene products were graphically represented. Proteins are depicted as nodes in various shapes representing functional class of protein. Lines depict the biological relationships between nodes. To determine the probability that the analyzed gene would be found in a network from Ingenuity Pathways Knowledge Base owing to random chance alone, IPA applies a Fisher's exact test. The network score or P value represents the significance of the focus gene enrichment. Enrichment of focus genes to diseases and functional categories was also evaluated in the IPA Knowledge Base. The P value, determined by a right-tailed Fisher's exact test, considers the number of identified focus genes and the total number of molecules known to be associated with these categories in the IPA knowledge database.
MAGENTA was used to explore pathway-based associations in the full GWAS data set. MAGENTA implements a GSEA-based approach that has been described 23 . Briefly, each gene in the genome is mapped to a single index SNP of the lowest P value within a 110 kb-upstream, 40 kb-downstream window. This P value, representing a gene score, is then corrected for confounding factors such as gene size, SNP density and LD-related properties in a regression model. Genes within the HLA region were excluded from analysis owing to difficulties in accounting for gene density and LD patterns. Each mapped gene in the genome is then ranked by its adjusted gene score. At a given significance threshold (95th and 75th percentiles of all gene scores), the observed number of gene scores in a given pathway, with a ranked score above the specified threshold percentile, is calculated. This observed statistic is then compared with 1,000,000 randomly permuted pathways of identical size. This generates an empirical GSEA P value for each pathway. Significance was determined when an individual pathway reached FDR <0.05 in either analysis (Supplementary Table 5 ). In total, 2,580 pathways from Gene Ontology, PANTHER, KEGG and Ingenuity were tested for enrichment of multiple modest associations with age at natural menopause.
GRAIL is designed to provide evidence for related biological function among a set of candidate genes. The method is based on connections between gene names and informative words extracted from PubMed abstracts by automated language processing techniques. Genes are considered related, and achieve a high similarity score, if they share informative words. For this analysis, the input for GRAIL was a list of candidate SNPs associated with age at natural menopause. From among candidate genes mapping near the candidate SNPs, GRAIL identifies genes with associated informative words that are significantly similar to informative words from other candidate genes. Genes with significant similarity scores are thus consistent with the set of candidate genes as a whole in having greater sharing of informative words than would be expected by chance, suggesting shared biological functions or even biological pathways. GRAIL was first applied to the lead SNPs from each of the replicating genome-wide significant loci using the 2006 edition of the database of genes and informative words. Separately, GRAIL was applied to a list of 66 SNPs, one from each locus that had at least one SNP meeting a FDR threshold of 0.05 from the QVALUE software in R 79 . For meta-analysis of age at natural menopause, the FDR < 0.05 threshold implied P < 2.8 × 10 −5 .
Candidate gene analysis. We explored the association of natural age of menopause with 125 candidate genes selected because of a reported relationship with ovarian function, including animal models in which gene mutations affect ovarian function (n = 37), human studies of menopause or isolated POI (n = 48), syndromes including ovarian failure (n = 4) or genes expressed in the ovary or female germ cells (n = 38; Supplementary Table 6 ). For each gene, the start and end of transcription was defined by the transcripts that span the largest portion of the genome. NCBI36/hg18 positions taken from the UCSC genome browser were used to define gene and SNP locations. Using the correlation measured from a set of ~850 independent Framingham Heart Study participants, we computed the effective number of independent SNPs for each chromosome 80 , and used the total (5,774) in a Bonferroni correction for multiple testing.
Pleiotropy of primary hits. Allelic pleiotropy was explored by comparing genome-wide-significant menopause signals to the online catalog of published GWAS (GWAS catalog; see URLs). All reported associations that reached
